Investment
Features
FeesSafety
Academy
More
Pluang+

Japanese yen stablecoin GYEN shuts down; holders must redeem by Nov 11, 2026

Market News
11 Sep 2026
Crypto Briefing
View Source
Neutral
Japanese yen stablecoin GYEN shuts down; holders must redeem by Nov 11, 2026

GMO-Z.com Trust Company is winding down its GYEN stablecoin, pegged to the Japanese yen, with a redemption period ending November 11, 2026. Holders can redeem tokens at par value through GMO Trust's platform after meeting KYC requirements. Coinbase, which suspended GYEN trading in May 2025, will convert remaining GYEN holdings to USDC by October 30, 2026. The shutdown marks the end of the first regulated yen-pegged stablecoin, which faced volatility and delisting issues since its 2021 launch on Coinbase Pro.

More News

Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...

Market News
Neutral
50 minutes ago
W. R. Berkley Q3 2026 earnings beat EPS estimates but revenue dips, net income down 13%.

W. R. Berkley Q3 2026 earnings beat EPS estimates but revenue dips, net income down 13%.

W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...

Company Fundamentals
Neutral
53 minutes ago
GE Aerospace Q3 earnings expected to show strong growth amid high investor expectations.

GE Aerospace Q3 earnings expected to show strong growth amid high investor expectations.

GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...

Company Fundamentals
Neutral
55 minutes ago
Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA

Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA

Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...

Market News
Bullish
55 minutes ago
Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.

Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.

On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...

Market News
Bearish
55 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App